We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Abbott Diagnostics

Download Mobile App




Image: New Portable PCR COVID-19 Test Kit from Visby Medical Secures FDA Emergency Use Authorization (Photo courtesy of Visby Medical)

New Portable PCR COVID-19 Test Kit from Visby Medical Secures FDA Emergency Use Authorization

A new portable PCR COVID-19 test kit has been granted Emergency Use Authorization (EUA) by the US Food and Drug Administration (FDA) for use in lab environments. More...
18 Sep 2020
Illustration

Key Biomarkers Could Identify Patients at Risk for Severe Reaction to COVID-19 Infection

Researchers have identified key markers that could help pinpoint patients who are bound to get a severe reaction to COVID-19 infection. This would help doctors provide the right treatments at the right time, potentially saving lives. More...
18 Sep 2020
Illustration

Stroke Scans Could Reveal COVID-19 Infection

New research has found that COVID-19 may be diagnosed on the same emergency scans intended to diagnose stroke. The findings have important implications in the management of patients presenting with suspected stroke through early identification of COVID-19. More...
18 Sep 2020
Image: SARS-CoV-2 emerging from the surface of cells (Photo courtesy of NIAID)

New CRISPR-Based Rapid Test Detects as Many Cases as Standard COVID-19 Diagnostic

A newly-developed CRISPR-based test has shown improved sensitivity and can detect nearly as many cases as the standard COVID-19 diagnostic. More...
18 Sep 2020
Image: A multi-layered, virus-specific immune response is important for controlling the virus during the acute phase of the infection and reducing COVID-19 disease severity (Photo courtesy of Crotty Lab/Cell Press)

Study Finds T Cells Lead in Controlling SARS-CoV-2, Suggesting COVID-19 Vaccines Must Elicit Broad Immune Response

A new study has found that T cells take the lead in controlling SARS-CoV-2 and reducing COVID-19 disease severity, suggesting that vaccine candidates should aim to elicit a broad immune response that include antibodies, helper and killer T cells to ensure protective immunity. More...
18 Sep 2020
Image: New Insight into Structural Mechanism of Coronavirus Receptor Binding to Aid Development of COVID-19 Treatments and Vaccines (Photo courtesy of Francis Crick Institute)

New Insight into Structural Mechanism of Coronavirus Receptor Binding to Aid Development of COVID-19 Treatments and Vaccines

New insight into the mechanism of infection of the SARS-CoV-2 coronavirus could equip research groups with the understanding needed to inform studies into COVID-19 vaccines and treatments. More...
18 Sep 2020
Image: Cidara’s Cloudbreak antiviral platform is a fundamentally new approach to treating and preventing viral infections (Photo courtesy of Cidara Therapeutics, Inc.)

New Generation of Long-Acting Immunotherapeutic Antivirals Aim to Prevent COVID-19/Flu ‘Twindemics’

A new generation of long-acting therapeutics designed for patients facing serious viral infections is aiming to prevent “twindemic” double threats of influenza and COVID-19. More...
18 Sep 2020
Copyright © 2000-2020 Globetech Media. All rights reserved.